1. Home
  2. TROO vs TTRX Comparison

TROO vs TTRX Comparison

Compare TROO & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$1.65

Market Cap

287.1M

Sector

Technology

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$13.49

Market Cap

298.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
TTRX
Founded
2005
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.1M
298.8M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
TROO
TTRX
Price
$1.65
$13.49
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
★ 259.5K
130.8K
Earning Date
05-01-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$2.57
52 Week High
$5.28
$16.45

Technical Indicators

Market Signals
Indicator
TROO
TTRX
Relative Strength Index (RSI) 36.45 59.23
Support Level $1.58 $3.80
Resistance Level $2.32 $14.39
Average True Range (ATR) 0.16 1.40
MACD -0.05 -0.16
Stochastic Oscillator 6.58 40.36

Price Performance

Historical Comparison
TROO
TTRX

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: